Multiple news services today are reporting that the Trump administration is ordering several U.S. government agencies conducting or funding scientific research to cease discussing its activities with the media or public officials. . . . → Read More: News Blackout Imposed on U.S. Science Agencies [Updated]
|
|||||
       |
 Comments are closed  Business conditions, Regulations  agriculture, biomedical, grant, health care, NIH, special Clinical trials in Europe are set to begin to test a non-invasive device that stimulates nerves and the spinal cord to treat neuromotor disorders. . . . → Read More: Neuro Device Company to Begin Clinical Trials in Europe Comments are closed Joint ventures/collaborations, New products biomedical, CE, clinical trials, engineering, entrepreneurs, Europe, life sciences, medical device, university A biopharmaceutical company in Sweden and children’s hospital in the U.S. are collaborating on research into deficiencies in cells’ energy components responsible for a number of genetic disorders. . . . → Read More: Biopharm, Hospital to Partner on Cell Energy Diseases Comments are closed Joint ventures/collaborations biomedical, Europe, genomics, life sciences, pharmaceuticals, preclinical A biotechnology company designed a new type of engineered T-cell from the immune system that more precisely targets tumors and stays away from healthy cells. . . . → Read More: Safer Engineered-Cell Cancer Immunotherapy Designed One comment - (Comments are closed) New products biomedical, biotechnology, cancer, Europe, genomics, life sciences, medical device, pharmaceuticals, preclinical The U.S. Food and Drug Administration is reorganizing its review of treatments for cancer into a structure that cuts across its traditional bureaucratic lines. . . . → Read More: FDA Begins Cancer Product Review Center Comments are closed Regulations biomedical, cancer, clinical trials, FDA, medical device, pharmaceuticals Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms. . . . → Read More: Lilly Acquires Migraine Therapy Company in $960M Deal Comments are closed Finance biomedical, clinical trials, equity, heart disease, investment, licensing, life sciences, merger, pharmaceuticals Intel Corporation and University of California in San Francisco are developing a data analytics platform that harnesses artificial intelligence to help front-line clinicians make better decisions for their patients. . . . → Read More: UC San Francisco, Intel Partner on Health Analytics Comments are closed Joint ventures/collaborations biomedical, computer science, engineering, life sciences, mathematics, medical device, physical sciences, software, university California will see a new form of blockchain cryptocurrency POS terminals in key medical marijuana dispensaries around the state. . . . → Read More: California Set to Pioneer Blockchain ATMs in MMJ Dispensaries Statewide A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions. . . . → Read More: Pharma Firms Start Non-Communicable Disease Initiative Comments are closed Joint ventures/collaborations Africa, Asia, biomedical, cancer, Europe, heart disease, life sciences, pharmaceuticals Researchers at University of Pennsylvania medical school developed an iPhone app to study sarcoidosis, a rare inflammatory disease where the cause is still unknown. . . . → Read More: Mobile App Designed to Study Rare Inflammatory Condition One comment - (Comments are closed) New products biomedical, engineering, life sciences, medical device, software, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts